The diagnostic and pharmacological variances of bipolar disorder versus attention-deficit/hyperactivity disorder.
Lysne
D Howard
DH
Peterson
Thomas
T
Erickson
Keith
K
Uriell
Michael
M
D000293:Adolescent; D017668:Age of Onset; D000927:Anticonvulsants / Q000627:therapeutic use*; D001289:Attention Deficit Disorder with Hyperactivity / Q000175:diagnosis* / Q000188:drug therapy* / Q000453:epidemiology; D001714:Bipolar Disorder / Q000175:diagnosis* / Q000188:drug therapy* / Q000453:epidemiology; D002220:Carbamazepine / Q000031:analogs & derivatives* / Q000627:therapeutic use; D000697:Central Nervous System Stimulants / Q000627:therapeutic use; D002648:Child; D015897:Comorbidity; D039721:Diagnostic and Statistical Manual of Mental Disorders; D006801:Humans; D000078330:Oxcarbazepine; D011569:Psychiatric Status Rating Scales / Q000706:statistics & numerical data; D016032:Randomized Controlled Trials as Topic / Q000592:standards; D012107:Research Design; D016896:Treatment Outcome
D000927:Anticonvulsants; D000697:Central Nervous System Stimulants; D002220:Carbamazepine; D000078330:Oxcarbazepine